CDK12 and ovarian carcinoma: In addition, BRCA1 promoter hypermethylation or mutational inactivation of CDK12 can downregulate transcription of BRCA1, thereby disrupting HR DNA repair in ovarian cancer, and then leading to metabolic reprogramming of ovarian cancer cells [65].